Newsfeeds - Spark Newswire

1 minute read

Uncategorized

Cathie Wood’s ARK Invest Posts Fund Purchases For Thursday, Apr. 22, 2021: RXRX, MASS, IONS, SKLZ, IRDM, DKNG, COIN, BEAM, SPFR, NIU, DDD, PDD, OKTA, TCEHY

April 22, 9:54 PM

Recursion Pharmaceuticals (RXRX) - 11,311 Shares 908 Devices (MASS) - 3,616 Ionis Pharmaceuticals (IONS) - 18,496 Skillz (SKLZ) - 1,222,207 Iridium Communications (IRDM) - 112,519 DraftKings (DKNG) -

BEAM

3 minute read

Uncategorized

Cathie Wood Loads Up Heavily On Debutant Uipath, Trims Tesla

By Rachit Vats

April 22, 12:44 AM

Cathie Wood-led Ark Investment Management on Wednesday snapped up millions of shares of the New York-based software automation company UiPath Inc (NYSE: PATH) on the day that it made its trading debut.

AMD

1 minute read

Uncategorized

Cathie Wood’s ARK Invest Posts Fund Purchases For Wednesday, Apr. 21, 2021: PATH, RXRX, IONS, MASS, SKLZ, IRDM, DKNG, COIN, BLI, BEAM, SPFR, NIU, DDD, TCEHY, PTON, PDD, NFLX, RTP

By Michael Horton

April 21, 7:57 PM

UiPath (PATH) - 2,738,930 Shares Recursion Pharmaceuticals (RXRX) - 710 Ionis Pharmaceuticals (IONS) - 108,698 908 Devices (MASS) - 3,359 Skillz (SKLZ) - 5,071,089 Iridium Communications (IRDM) -

BEAM

2 minute read

Uncategorized

Cathie Wood Loads Up On DraftKings, Coinbase, Palantir, Sells Nvidia, Square

By Rachit Vats

April 21, 3:29 AM

Cathie Wood-led Ark Investment Management on Tuesday snapped up another 236,348 shares of cryptocurrency exchange Coinbase Global Inc (NASDAQ: COIN).

ARKF

1 minute read

Uncategorized

Cathie Wood’s ARK Invest Posts Fund Purchases For Tuesday, Apr. 20, 2021: JD, OPEN, PDD, RXRX, IONS, PLTR, DKNG, COIN, BLI, BEAM, TSP, WKHS, SPFR, NIU, IRDM, DDD, TCEHY, RBLX, PTON, OKTA, RTP

By Michael Horton

April 20, 9:56 PM

JD.Com (JD) - 88,313 Shares Opendoor Technologies (OPEN) - 137,988 Pinduoduo (PDD) - 33,037 Recursion Pharmaceuticals (RXRX) - 5,254 Ionis Pharmaceuticals (IONS) - 90,284 Palantir Technologies (PLTR) -

BEAM

1 minute read

Akcea And Ionis Report Topline Phase 2 Results Of AKCEA-APOCIII-L Rx; Primary And Key Secondary Endpoints Were Met With ‘Significant Reduction’ In apoC-III And Triglyceride Levels

By Benzinga Newsdesk

January 22, 8:07 AM

Favorable safety and tolerability were demonstrated in hypertriglyceridemia patients in the study Primary and key secondary endpoints were…

AKCA

Latest news

Cathie Wood’s ARK Invest Posts Fund Purchases For Thursday, Apr. 22, 2021: RXRX, MASS, IONS, SKLZ, IRDM, DKNG, COIN, BEAM, SPFR, NIU, DDD, PDD, OKTA, TCEHY

Cathie Wood Loads Up Heavily On Debutant Uipath, Trims Tesla

Cathie Wood’s ARK Invest Posts Fund Purchases For Wednesday, Apr. 21, 2021: PATH, RXRX, IONS, MASS, SKLZ, IRDM, DKNG, COIN, BLI, BEAM, SPFR, NIU, DDD, TCEHY, PTON, PDD, NFLX, RTP

Cathie Wood Loads Up On DraftKings, Coinbase, Palantir, Sells Nvidia, Square

Cathie Wood’s ARK Invest Posts Fund Purchases For Tuesday, Apr. 20, 2021: JD, OPEN, PDD, RXRX, IONS, PLTR, DKNG, COIN, BLI, BEAM, TSP, WKHS, SPFR, NIU, IRDM, DDD, TCEHY, RBLX, PTON, OKTA, RTP

Akcea And Ionis Report Topline Phase 2 Results Of AKCEA-APOCIII-L Rx; Primary And Key Secondary Endpoints Were Met With ‘Significant Reduction’ In apoC-III And Triglyceride Levels